JPH10120554A - Quickly dispersible particle containing inorganic antiacid, and its production and internal medicine to be suspended on use - Google Patents

Quickly dispersible particle containing inorganic antiacid, and its production and internal medicine to be suspended on use

Info

Publication number
JPH10120554A
JPH10120554A JP29450396A JP29450396A JPH10120554A JP H10120554 A JPH10120554 A JP H10120554A JP 29450396 A JP29450396 A JP 29450396A JP 29450396 A JP29450396 A JP 29450396A JP H10120554 A JPH10120554 A JP H10120554A
Authority
JP
Japan
Prior art keywords
antacid
inorganic
particles
dispersing
sugar alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP29450396A
Other languages
Japanese (ja)
Other versions
JP3961596B2 (en
Inventor
Tetsuo Shirai
徹夫 白井
Shinichiro Yokoi
慎一郎 横井
Takashi Maeda
隆 前田
Kiyoshi Takami
潔 高見
Mitsuji Inagaki
満二 稲垣
Tatsuo Murakami
達夫 村上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Chemical Industries Co Ltd
Original Assignee
Fuji Chemical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chemical Industries Co Ltd filed Critical Fuji Chemical Industries Co Ltd
Priority to JP29450396A priority Critical patent/JP3961596B2/en
Publication of JPH10120554A publication Critical patent/JPH10120554A/en
Application granted granted Critical
Publication of JP3961596B2 publication Critical patent/JP3961596B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject particles capable of being suspended in an aqueous medium in a short time by dispersing an inorganic antiacid, a sugar alcohol and a disintegrating agent and subsequently spray-drying the suspension. SOLUTION: The particles are obtained by homogeneously dispersing an inorganic antiacid (e.g. aluminum hydroxide gel), a sugar alcohol (e.g. mannitol) and a disintegrating agent (e.g. dextrin) in an aqueous medium, and subsequently spray-drying the dispersion. The inorganic antiacid, the sugar alcohol and the disintegrating agent and compounded in amounts of 50-95wt.%, 1-35wt.% and 1-15wt.%, respectively, based on the whole weight of the particles. The particles have large hardness, are hardly pulverized, are easy in storage, can rapidly be dispersed in water, and give mild and non-rough mount touch, since the particles are fine. The particles are convenient for carriage, can rapidly and homogeneously be dispersed and suspended in an aqueous medium, and can orally be administered without giving any uncomfortable touch. The particles are useful for improving the syndromes of digestion acceleration, indigestion, anorexia, gluttony, dull feelings in stomachs, pyrosis, feelings of fullness in stomach and abdomen parts due to indigestion, stomach ache, gastric hyperacidity, etc.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、無機制酸剤、糖アルコ
ール及び崩壊剤を均一に分散させ、噴霧乾燥させること
により得られる、極めて短時間に水媒質に懸濁分散可能
な、無機制酸剤含有速分散性造粒物及びその製造方法に
関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an inorganic antacid, sugar alcohol and disintegrant obtained by uniformly dispersing and spray-drying an inorganic antacid, a sugar alcohol and a disintegrant, which can be suspended and dispersed in an aqueous medium in a very short time. The present invention relates to an acid agent-containing rapidly dispersible granulated product and a method for producing the granulated product.

【0002】[0002]

【従来技術】医療用制酸剤は、消化促進、消化不良、食
欲不振、食べ過ぎ、胃もたれ、胸つかえ、消化不良によ
る胃部・腹部膨満感、胃痛、胃酸過多等の症状の改善に
用いられる。これらは、通常、細粒剤、顆粒剤及び錠剤
等の固形剤として又は液剤として用いられる。これら細
粒剤、顆粒剤及び錠剤は、軽量であり、嵩張らないので
携帯には便利であるが、服用後の胃内での崩壊や分散に
時間を要し、迅速に制酸作用を出現させるとういう面で
は問題があった。また、錠剤等は有効量を投与すると形
状が大きくなり、健常人でも服用時に咽頭や食道に付着
し、滞留することがよく起こりうる。特に咀嚼力や嚥下
力が劣る小児や老人のために飲みやすく改良した制酸剤
の開発が望まれていた。上記問題点を改善する方法とし
て懸濁液剤があるが、懸濁液剤は、細粒剤、顆粒剤及び
錠剤等の固形剤よりも制酸作用の発現が早い点では優れ
ているが、液剤であるがため容器の包装形態が大きく、
重量があることから携帯に不便であり、また、服用時に
は均一懸濁分散化が必要であること、保管中に経時的な
微生物の増菌化や、含有成分の安定性等に多くの問題点
があった。
2. Description of the Related Art Medical antacids are used for improving symptoms such as acceleration of digestion, indigestion, loss of appetite, overeating, leaning of the stomach, chest stomach, stomach / abdominal distension due to indigestion, stomach pain, and gastric hyperacidity. Can be These are usually used as solid preparations such as fine granules, granules and tablets or as liquid preparations. These fine granules, granules and tablets are lightweight and non-bulky, so they are convenient to carry, but they take time to disintegrate and disperse in the stomach after taking them, and quickly show antacid action. There was a problem in that respect. In addition, tablets and the like become large in shape when administered in an effective amount, and often adhere to the pharynx and esophagus and take a stagnation during administration even in healthy individuals. In particular, there has been a demand for the development of an antacid that is easy to drink and improved for children and the elderly, who have poor chewing and swallowing power. Suspensions are a method of solving the above problems. Suspensions are superior in that they exhibit an antacid action earlier than solids such as fine granules, granules, and tablets. Because of this, the packaging form of the container is large,
Due to its weight, it is inconvenient to carry, and it requires uniform suspension and dispersion when taking it.There are many problems with the enrichment of microorganisms over time during storage and the stability of contained components. was there.

【0003】[0003]

【発明が解決しようとする課題】本発明は、無機制酸
剤、糖アルコール及び崩壊剤を均一に分散させ、噴霧乾
燥させることにより得られる、極めて短時間に水媒質に
懸濁分散可能な、無機制酸剤含有速分散性造粒物及びそ
の製造方法を提供することを目的とする。より詳しく
は、携帯に便利で、服用時、水媒質に極めて迅速に均一
に懸濁分散し、且つ違和感を持たずに服用し得る細粒状
無機制酸剤含有速分散性造粒物を提供することを目的と
する。
DISCLOSURE OF THE INVENTION The present invention relates to an inorganic antacid, a sugar alcohol and a disintegrant which are uniformly dispersed and spray-dried, and can be suspended and dispersed in an aqueous medium in a very short time. An object of the present invention is to provide a fast-dispersing granule containing an inorganic antacid and a method for producing the same. More specifically, the present invention provides a fine-granular inorganic antacid-containing fast-dispersing granule that is convenient to carry, can be rapidly and uniformly suspended and dispersed in an aqueous medium when taken, and can be taken without giving a sense of incongruity. The purpose is to:

【0004】[0004]

【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意研究を重ねた結果、水媒質中で無
機制酸剤、糖アルコール及び崩壊剤を均一に分散させ、
噴霧乾燥させることにより得られる無機制酸剤含有速分
散性造粒物が、上記問題点を解決し得ることを見し、本
発明に至った。本発明の無機制酸剤含有速分散性造粒物
は、粒子強度の硬い細粒であるにもかかわらず、この粒
子を水に分散させると1〜3分内という極めて短時間
に、均一に分散した懸濁液となる。
Means for Solving the Problems The present inventors have conducted intensive studies to solve the above problems, and as a result, uniformly disperse the inorganic antacid, sugar alcohol and disintegrant in an aqueous medium,
The present inventors have found that a rapidly dispersible granule containing an inorganic antacid obtained by spray-drying can solve the above-mentioned problems, and have reached the present invention. Although the inorganic antacid-containing fast-dispersing granules of the present invention are hard fine particles having a high particle strength, when these particles are dispersed in water, they can be uniformly dispersed in an extremely short time of 1 to 3 minutes. It becomes a dispersed suspension.

【0005】本発明において用いられる無機制酸剤とし
ては、水に不溶性の金属酸化物、金属水酸化物、金属酸
塩又は複合金属化合物等が用いられる。より具体的に
は、酸化マグネシウム等の金属酸化物、乾燥水酸化アル
ミニウムゲル、水酸化アルミニウムゲル、水酸化マグネ
シウム等の金属水酸化物、沈降炭酸カルシウム、炭酸マ
グネシウム等の金属炭酸塩、又はメタケイ酸アルミン酸
マグネシウム、ケイ酸アルミン酸マグネシウム、水酸化
アルミナマグネシア、合成ヒドロタルサイト等の複合金
属化合物等の群から選ばれる1種以上を挙げることがで
きる。好ましくは、無機制酸剤が水酸化アルミニウムゲ
ル、炭酸マグネシウム、メタケイ酸アルミン酸マグネシ
ウム、ケイ酸アルミン酸マグネシウム、合成ヒドロキシ
タルサイト、乾燥水酸化アルミニウムゲル、水酸化マグ
ネシウム、沈降炭酸カルシウムの群から選ばれる1種以
上の組み合わせである。
As the inorganic antacid used in the present invention, water-insoluble metal oxides, metal hydroxides, metal salts or composite metal compounds are used. More specifically, metal oxides such as magnesium oxide, dried aluminum hydroxide gel, aluminum hydroxide gel, metal hydroxides such as magnesium hydroxide, precipitated calcium carbonate, metal carbonates such as magnesium carbonate, or metasilicic acid At least one selected from the group consisting of composite metal compounds such as magnesium aluminate, magnesium silicate aluminate, magnesia hydroxide alumina, and synthetic hydrotalcite can be given. Preferably, the inorganic antacid is selected from the group consisting of aluminum hydroxide gel, magnesium carbonate, magnesium metasilicate aluminate, magnesium aluminate silicate, synthetic hydroxytalcite, dry aluminum hydroxide gel, magnesium hydroxide, precipitated calcium carbonate. One or more combinations.

【0006】これら無機制酸剤の配合量は、無機制酸剤
含有速分散性造粒物の全量に対して通常50〜95重量
%、好ましくは70〜95重量%、より好ましくは70
〜85重量%である。なお、これらの無機制酸剤は天然
物または合成によって得られるものであってもよく、す
でに粉末となったものを用いる場合にはできるだけ粉砕
して微粉として用いる方がよい。粒子径としては、15
μm以下のものが好ましい。
The amount of the inorganic antacid is usually 50 to 95% by weight, preferably 70 to 95% by weight, more preferably 70 to 95% by weight, based on the total amount of the inorganic antacid-containing fast-dispersing granules.
~ 85% by weight. In addition, these inorganic antacids may be natural products or those obtained by synthesis, and when using those already in powder form, it is better to pulverize as much as possible and use them as fine powder. The particle size is 15
Those having a size of μm or less are preferred.

【0007】糖アルコールとしては、糖類の分子内の還
元性末端基が水素添加又は加水分解することにより得ら
れるものであり、原料糖の違いにより種々の糖アルコー
ルがある。本発明ではいずれを用いてもよくまた併用し
てもよい。具体的には、例えば、ソルビトール、マンニ
トール、キシリトール、還元麦芽糖水飴、エリスリトー
ル、マルチトール、ラクチトール又はパラチニット等を
挙げることができ、好ましくは、ソルビトール、マンニ
トール、キシリトール、還元麦芽糖水飴、エリスリトー
ル等である。これらの糖アルコールの配合量は、本発明
の無機制酸剤含有速分散性造粒物の全量に対して1〜3
5重量%、好ましくは1〜25重量%、より好ましくは
5〜20重量%である。
[0007] The sugar alcohol is obtained by hydrogenating or hydrolyzing a reducing terminal group in the molecule of the saccharide, and there are various sugar alcohols depending on the difference of the raw sugar. In the present invention, any of these may be used or they may be used in combination. Specific examples include sorbitol, mannitol, xylitol, reduced maltose syrup, erythritol, maltitol, lactitol or palatinit, and the like, and preferably sorbitol, mannitol, xylitol, reduced maltose syrup, erythritol and the like. The mixing amount of these sugar alcohols is 1 to 3 with respect to the total amount of the inorganic antacid-containing fast-dispersing granules of the present invention.
It is 5% by weight, preferably 1 to 25% by weight, more preferably 5 to 20% by weight.

【0008】崩壊剤としては、デンプン系、セルロース
系、ビニール系等の崩壊剤が用いられる。より具体的に
は、トウモロコシデンプン、ばれいしょでんぷん、デキ
ストリン、ヒドロキシプロピルスターチ、部分アルファ
化デンプン、カルボキシメチルスターチナトリウム等の
デンプン系崩壊剤、カルメロースカルシウム、カルメロ
ース、架橋カルボキシメチルセルロースナトリウム、低
置換度ヒドロキシプロピルセルロース等のセルロース系
崩壊剤、架橋ポリビニルピロリドン等のビニル系崩壊剤
からなる群から選ばれる1種以上を適宜組み合わせて用
いることができる。好ましくは、トウモロコシデンプ
ン、デキストリン、カルメロースカルシウム、部分アル
ファー化デンプンからなる群から選ばれる1種以上の組
み合わせである。これらの配合量は、無機制酸剤含有速
分散性造粒物の全量に対して1〜15重量%、好ましく
は5〜10重量%である。
As the disintegrant, disintegrants of starch type, cellulose type, vinyl type and the like are used. More specifically, corn starch, potato starch, dextrin, hydroxypropyl starch, partially pregelatinized starch, starch disintegrants such as sodium carboxymethyl starch, carmellose calcium, carmellose, cross-linked sodium carboxymethyl cellulose, low-substituted hydroxypropyl One or more selected from the group consisting of cellulose-based disintegrants such as cellulose and vinyl-based disintegrants such as cross-linked polyvinyl pyrrolidone can be used in appropriate combination. Preferably, it is at least one combination selected from the group consisting of corn starch, dextrin, carmellose calcium, and partially pregelatinized starch. The amount of these components is 1 to 15% by weight, preferably 5 to 10% by weight, based on the total amount of the inorganic antacid-containing rapidly dispersible granules.

【0009】本発明の無機制酸剤含有速分散性造粒物に
は上記成分のほかに、ケイヒ、チョウジ、赤芽柏、カン
ゾウ等の生薬類、ジメチルポリシロキサン又はシリコン
樹脂等の消泡剤、パラオキシ安息香酸メチル、安息香酸
ナトリウム等の防腐剤、ハッカ油、メントール、レモン
油等の香料、サッカリンナトリウム、グリチルリチン酸
等の甘味剤等を必要に応じて加えることができる。これ
らの成分は、医薬品や食品等の製造に際し、一般的に用
いられるものを適宜、単独または組合せて使用すること
ができる。
[0009] In addition to the above components, the inorganic antacid-containing fast-dispersing granules of the present invention may further contain crude drugs such as cinnamon, clove, red bud, licorice, etc .; Preservatives such as methyl benzoate and sodium benzoate, flavors such as peppermint oil, menthol and lemon oil, and sweeteners such as saccharin sodium and glycyrrhizic acid can be added as required. As these components, those commonly used in the production of pharmaceuticals, foods and the like can be used alone or in combination as appropriate.

【0010】本発明の無機制酸剤含有速分散性造粒物の
調製は、湿式造粒方法であるが、噴霧乾燥造粒機にて行
うことを特徴とする。一方、通常の湿式造粒方法で、加
水練合機、押し出し造粒機、撹拌造粒機又は転動造粒機
等で調製した場合は、原料粉体に水を加えて練合や造粒
する時に練り込みによる圧密が加わるため、造粒物が高
密度で且つ凝集性の強い物性となり、その結果得られた
造粒物は水への分散性が悪いものとなる。また、高密度
の造粒物の物性を改善するために水の一部をエタノール
等の有機溶媒に換える手段もあるが、有機溶媒量が多く
なると乾燥後の造粒物は形状が崩れやすくなり、粉立ち
が激しく、且つ流動性が悪くなる等取扱上不便となる。
水と有機溶媒の最適混合比を設定し、目的とする物性を
有する造粒物を得ることは至難であることに加え、造粒
物に有機溶媒が残留する等問題もあり、好ましい方法で
はない。
The preparation of the rapidly dispersible granules containing an inorganic antacid according to the present invention is a wet granulation method, which is characterized in that the granulation is carried out by a spray drying granulator. On the other hand, when prepared by a conventional wet granulation method using a water kneading machine, an extrusion granulator, a stirring granulator or a tumbling granulator, water is added to the raw material powder to knead or granulate. Since the consolidation due to kneading is added at the time of mixing, the granulated material has high density and strong cohesive properties, and as a result, the obtained granulated material has poor dispersibility in water. There is also a means of replacing a part of water with an organic solvent such as ethanol in order to improve the physical properties of the high-density granulated material.However, when the amount of the organic solvent is large, the dried granulated material tends to lose its shape. It is inconvenient to handle such as severe powdering and poor fluidity.
Setting the optimum mixing ratio of water and the organic solvent, it is extremely difficult to obtain a granulated product having the desired physical properties, and there is a problem that the organic solvent remains in the granulated product, which is not a preferable method. .

【0011】本発明の無機制酸剤含有速分散性造粒物
は、噴霧乾燥造粒法を用いて水系で調製することがで
き、下記の特徴ある物性を有する。すなわち、得られた
造粒物はマイクロスコープ(キーエンスVH−610
0)での観察から細粒状の球形物であり、且つ極めて流
動性が良く(安息角が31〜34°)、後工程での輸
送、混合及び分包等においてほとんど粒子の崩れがな
く、しかも造粒物がポーラスな凝集体となるため水媒質
に均一に分散し易い特徴を有し、1〜3分以内という極
めて短時間に、均一に分散した懸濁液剤となる。この優
れた物性を有する本発明の無機制酸剤含有速分散性造粒
物を有効成分として含有することを特徴とする用時懸濁
内服用制酸剤として使用することができる。
The rapidly dispersible granules containing an inorganic antacid according to the present invention can be prepared in an aqueous system by using a spray drying granulation method, and have the following characteristic properties. That is, the obtained granules were obtained using a microscope (Keyence VH-610).
Observation at 0) shows that the product is a fine-grained sphere, has extremely good fluidity (angle of repose is 31 to 34 °), and has almost no particle collapse during transportation, mixing, and packaging in a later step. Since the granulated material is a porous aggregate, it has a characteristic of being easily dispersed uniformly in an aqueous medium, and becomes a uniformly dispersed suspension in an extremely short time of 1 to 3 minutes or less. The inorganic antacid-containing fast-dispersing granules containing the inorganic antacid of the present invention having excellent physical properties can be used as an antacid for internal use in suspension when used, which is characterized by containing as an active ingredient.

【0012】本発明の造粒物が、細粒状で且つ粒子強度
が硬く、水への分散性がよい物性をもたらす機構は次の
ように推定できる。すなわち、糖アルコールが噴霧乾燥
造粒時に無機制酸剤の凝集粒子間に介在し収縮性を抑え
る働きをすると同時に、その一部が粒子表面に析出し皮
膜形成するために水濡れが良くなり、その結果として細
粒状の粒子内の崩壊剤へ水を呼び込み易くすることによ
り、分散性が速くて均一分散をもたらすものとみる。こ
の粒子表面の皮膜形成が粒子強度を高める働きもしてい
る。
The mechanism by which the granulated product of the present invention provides physical properties that are fine-grained, have a high particle strength, and have good dispersibility in water can be estimated as follows. That is, at the same time that the sugar alcohol acts between the aggregated particles of the inorganic antacid during spray-drying granulation and acts to suppress shrinkage, and at the same time, a portion thereof precipitates on the particle surface to form a film, so that the water wetting is improved, As a result, by facilitating the incorporation of water into the disintegrant in the fine-grained particles, it is considered that the dispersibility is high and uniform dispersion is achieved. The formation of a film on the surface of the particles also functions to increase the particle strength.

【0013】本発明の無機制酸剤含有速分散性造粒物の
製造方法及び生成物の理化学的性質を以下の実施例及び
比較例に示す。なお、各々の実施例又は比較例の処方の
成分量は表1に、その理化学的性質は表2に、また水分
散時の口中の官能試験の結果は表3に示した。
The following examples and comparative examples show the method for producing the inorganic antacid-containing fast-dispersing granules of the present invention and the physicochemical properties of the products. Table 1 shows the amounts of the components of the formulations of Examples and Comparative Examples, Table 2 shows the physicochemical properties thereof, and Table 3 shows the results of the sensory test in the mouth when dispersed in water.

【0014】[0014]

【実施例】【Example】

実施例1 50Lの容器に精製水25kgを入れ、撹拌しながらマ
ンニトール0.50kg、デキストリン0.48kg、
パラオキシ安息香酸メチル0.01kg、アスパルテム
0.01kg、乾燥水酸化アルミニウムゲル4.50k
g及び水酸化マグネシウム4.00kgをそれぞれ順次
加え、ホモジナイザーで均一に分散させる。その後、噴
霧乾燥造粒機(ニロ社製、S−50N/R型)を用い、
ノズル口径1.4mm、入熱温度230〜240℃、排
熱温度130〜140℃で、フィード圧10〜12kg
/cm2で噴霧乾燥し、造粒物9.5kgを得た。得ら
れた造粒物の見掛け密度は0.43であり、安息角は3
2°であった。
Example 1 25 kg of purified water was placed in a 50 L container, and while stirring, mannitol 0.50 kg, dextrin 0.48 kg,
Methyl paraoxybenzoate 0.01 kg, aspartame 0.01 kg, dried aluminum hydroxide gel 4.50 k
g and 4.00 kg of magnesium hydroxide are sequentially added, and the mixture is uniformly dispersed with a homogenizer. Then, using a spray-drying granulator (N-50, S-50N / R type)
Nozzle diameter 1.4mm, heat input temperature 230-240 ° C, exhaust heat temperature 130-140 ° C, feed pressure 10-12kg
/ Cm 2 to obtain 9.5 kg of granules. The apparent density of the obtained granules is 0.43 and the angle of repose is 3
2 °.

【0015】実施例2〜5 実施例1の方法に準拠して表1の実施例2〜5の欄に示
す処方により、実施例2〜5の各々の球形造粒物を得
た。その収量は、実施例2(9.2kg)、実施例3
(9.3kg)、実施例4(9.4kg)及び実施例5
(9.4kg)であった。
Examples 2 to 5 Spherical granules of Examples 2 to 5 were obtained according to the formulations shown in the columns of Examples 2 to 5 in Table 1 in accordance with the method of Example 1. The yield was as shown in Example 2 (9.2 kg), Example 3
(9.3 kg), Example 4 (9.4 kg) and Example 5
(9.4 kg).

【0016】比較例1及び2 実施例1の方法に準拠して表1の比較例1及び2に示す
処方により、比較例1及び2の球形造粒物を得た。その
収量は、比較例1(9.3kg)及び比較例2(9.4
kg)であった。
Comparative Examples 1 and 2 Spherical granules of Comparative Examples 1 and 2 were obtained according to the formulations shown in Comparative Examples 1 and 2 in Table 1 based on the method of Example 1. The yield was as follows: Comparative Example 1 (9.3 kg) and Comparative Example 2 (9.4
kg).

【0017】比較例3及び4 表1の比較例3及び4の欄に示す処方原料を撹拌造粒機
(パウレック製、バーチカル・グラニュレーター、VG
−25)に投入後、ブレード回転数300r.p.
m.、クロススクリュー回転数3000r.p.m.で
5分間混合し、次に水3.70kgを5分間で添加し、
更に5分間撹拌して得られた造粒物を棚式乾燥機で85
℃で7時間乾燥後、不定形造粒物を得た。
Comparative Examples 3 and 4 Prescription raw materials shown in the columns of Comparative Examples 3 and 4 in Table 1 were mixed with a stirring granulator (manufactured by Powrex, Vertical Granulator, VG).
-25), the blade rotation speed is 300 r. p.
m. , Cross screw rotation speed 3000r. p. m. And mix for 5 minutes, then add 3.70 kg of water in 5 minutes,
The granulated product obtained by further stirring for 5 minutes is subjected to 85
After drying at 7 ° C. for 7 hours, an amorphous granule was obtained.

【0018】比較例5 比較例3及び4の方法に準拠して、表1の比較例5の欄
に示す処方で70%エタノールを4.00kg用いて撹
拌造粒し、以下、比較例3と4の同様の方法で調製し、
不定形造粒物を得た。
Comparative Example 5 In accordance with the method of Comparative Examples 3 and 4, the mixture was stirred and granulated using 4.00 kg of 70% ethanol according to the formulation shown in the column of Comparative Example 5 in Table 1. Prepared in a similar manner as in 4,
An amorphous granulate was obtained.

【0019】上記実施例1〜5及び比較例1〜5の処方
を下記表1にまとめて示す。表中の各成分は重量(k
g)で示されていて、各成分の合計量は実施例1〜5及
び比較例1〜2では10.0kgであり、比較例3〜5
では各々5.0kgである。
The formulations of Examples 1 to 5 and Comparative Examples 1 to 5 are shown in Table 1 below. Each component in the table is weight (k
g), the total amount of each component is 10.0 kg in Examples 1 to 5 and Comparative Examples 1 and 2, and Comparative Examples 3 to 5
Each weighs 5.0 kg.

【0020】下記表2は各実施例及び比較例で得られた
生成物の粒子強度試験〔74μmpass(%)〕、崩
壊試験(分)、水分散での粒度分布〔50%平均粒子径
(μm)、最大粒子径(μm)〕及び安息角の測定結果
を示す。
Table 2 below shows the particle strength test [74 μpass (%)], the disintegration test (minute), the particle size distribution in water dispersion [50% average particle diameter (μm) of the products obtained in each of Examples and Comparative Examples. ), Maximum particle diameter (μm)] and the angle of repose are shown.

【0021】また、下記表3は、上記各実施例及び比較
例で得られた造粒物の水分散時の口中での官能試験の結
果を示す。表中、の記号は以下の意味を示す(◎は全く
ざらつきがない、○はほとんどざらつきがない、△は少
しざらつきがある、×はざらつきが強い)。
Table 3 below shows the results of a sensory test in the mouth when the granules obtained in the above Examples and Comparative Examples were dispersed in water. In the table, the symbols have the following meanings (◎ indicates no roughness, ○ indicates almost no roughness, Δ indicates slight roughness, and × indicates strong roughness).

【0022】[0022]

【表1】 [Table 1]

【0023】[0023]

【表2】 [Table 2]

【0024】[0024]

【表3】 [Table 3]

【0025】試験方法 (1)粒子強度試験 試料10gを秤り、錠剤摩損度試験器(萱垣医理科製4
G−18型)にφ10mm、6R、φ2mmのガラスビ
ーズ10gと共に入れ、10分間回転させた後、74μ
mの篩で試料を篩過し、通過(pass)量を秤量し、
試料10gで除して74μm通過量をパーセンテージで
表す。この数値が高いほど粒子強度が弱く粉化しやす
い。
Test Method (1) Particle Strength Test A sample of 10 g was weighed, and a tablet friability tester (4 manufactured by Kayagaki Medical Science Co., Ltd.)
G-18 type) together with 10 g of glass beads of φ10 mm, 6R, φ2 mm, and rotated for 10 minutes.
m, sieve the sample through a sieve, weigh the amount of pass,
Divide by 10 g of sample and show the amount of 74 μm passage as a percentage. The higher the value, the weaker the particle strength and the easier it is to powder.

【0026】(2)崩壊試験 日局崩壊試験装置を用いて以下の方法で崩壊試験を行っ
た。試料をメッシュ150μmの篩でふるい、篩い上の
残留物0.1gをメッシュ150μmの網を取り付けた
補助筒中に入れ、37℃水中で上下運動を行う。試料の
残留物が補助筒内に、認めなくなるまでの時間を測定し
た。崩壊の早いものほど短時間で残留物が消失する。
(2) Disintegration Test A disintegration test was conducted by the following method using a disintegration test apparatus of the Japanese Pharmacopoeia. The sample is sieved with a 150 μm mesh sieve, and 0.1 g of the residue on the sieve is placed in an auxiliary cylinder equipped with a 150 μm mesh net, and vertically moved in water at 37 ° C. The time until no residue of the sample was observed in the auxiliary cylinder was measured. The faster the disintegration, the shorter the residue disappears.

【0027】(3)水分散での粒度分布測定試験 レザー回折式粒度分布測定装置(日機装製とマイクロト
ラックMKIISPA型)を使って、水に分散させた試
料の粒度分布を測定した。50%平均粒子径と最大粒子
径を表4と表5に示した。
(3) Particle Size Distribution Measurement Test in Water Dispersion The particle size distribution of the sample dispersed in water was measured using a laser diffraction type particle size distribution analyzer (Nikkiso and Microtrac MKIISPA type). Tables 4 and 5 show the 50% average particle size and the maximum particle size.

【0028】(4)安息角の測定 安息角測定装置(パウダーテスタ、ホソカワミクロン
製)を用い、所定量の試料を静かに振とうさせながら、
測定用テーブルに落とし、テーブルの周囲から試料がこ
ぼれはじめたら振とうを停止し、分度器で安息角を測定
する。この安息角が低いほど流動性が良い。
(4) Measurement of angle of repose Using a repose angle measuring device (powder tester, manufactured by Hosokawa Micron), while gently shaking a predetermined amount of sample,
Drop the sample on the measuring table. When the sample starts to spill from around the table, stop shaking and measure the angle of repose with a protractor. The lower the angle of repose, the better the fluidity.

【0029】(5)水分散時の口中での官能試験 口中でのざらつきをパネラー5名(男子3名、女子2
名)による官能試験によって評価した。すなわち、水1
0mL中に試料1gを添加し、手で軽く揺すり分散さ
せ、懸濁液剤とし、3分後に口に全量を含みざらつき感
を評価した。
(5) Sensory Test in Mouth at the Time of Dispersion in Water 5 panelists (3 boys, 2 girls)
) Was evaluated by a sensory test. That is, water 1
1 g of the sample was added to 0 mL, and the mixture was slightly shaken and dispersed by hand to prepare a suspension. After 3 minutes, the whole mouth was contained and the roughness was evaluated.

【0030】表2の結果からは、実施例1〜5の処方得
られる本発明の造粒物は、粒子強度が硬くて粉化し難
く、且つ水への分散が速い、また分散粒子が微細で原料
粒子に近い状態になり口に含んでもまろやかでざらつき
感がないことが判る。一方、比較例1と比較例5の処方
による造粒物は粒子強度が弱く、水への均一分散もやや
遅く口に含むとざらつき感がある。比較例2、比較例3
及び比較例4の処方による造粒物は粒子強度は硬く粉化
し難いものであるが、水に分散させた場合は崩壊が遅く
凝集物が多く残り、また口に含むとざらつき感が強い。
From the results shown in Table 2, it can be seen that the granules of the present invention obtained from the formulations of Examples 1 to 5 have a high particle strength, are hard to be powdered, are rapidly dispersed in water, and have fine dispersed particles. It turns out that it is in a state close to the raw material particles, and even if it is contained in the mouth, it is not round and rough. On the other hand, the granulated products according to the formulations of Comparative Examples 1 and 5 have a low particle strength, and even when dispersed in water a little later, they have a rough feeling. Comparative Example 2, Comparative Example 3
The granulated product according to the formulation of Comparative Example 4 has a high particle strength and is hardly powdered. However, when dispersed in water, it disintegrates slowly and many agglomerates remain.

【0031】[0031]

【発明の効果】本発明により、無機制酸剤、糖アルコー
ル及び崩壊剤を均一に分散させ、噴霧乾燥させることに
より得られる、極めて短時間に水媒質に懸濁分散可能
な、無機制酸剤含有速分散性造粒物及びその製造方法を
提供することができた。本発明の造粒物は、粒子強度が
硬くて粉化し難く保管が容易であり、且つ水への分散が
速く、また分散粒子が微細で原料粒子に近い状態になり
口に含んでもまろやかでざらつき感がなく、用時懸濁内
服制酸剤として最適である。さらにこの造粒物は、携帯
に便利で、服用時、水媒質に極めて迅速に均一に懸濁分
散し、且つ違和感を持たずに服用し得る細粒状無機制酸
剤含有速分散性造粒物であり、消化促進、消化不良、食
欲不振、食べ過ぎ、胃もたれ、胸つかえ、消化不良によ
る胃部・腹部膨満感、胃痛、胃酸過多等の症状の改善に
用いられる用時懸濁内服用制酸剤として極めて有用であ
る。
Industrial Applicability According to the present invention, an inorganic antacid which can be suspended and dispersed in an aqueous medium in a very short time, obtained by uniformly dispersing an inorganic antacid, a sugar alcohol and a disintegrant and spray-drying it. It was possible to provide a rapidly dispersible granulated material and a method for producing the same. The granulated product of the present invention has a hard particle strength, is hard to be powdered, is easy to store, is quick to be dispersed in water, and is in a state where the dispersed particles are fine and close to the raw material particles and are round and rough even when included in the mouth. It has no sensation and is most suitable as an antacid in suspension when used. Further, the granulated material is a fast-dispersing granule containing a fine inorganic antacid, which is convenient to carry, can be suspended and dispersed very quickly and uniformly in an aqueous medium when taken, and can be taken without feeling uncomfortable. It is used to improve digestion, indigestion, anorexia, eating too much, leaning the stomach, holding on to the chest, stomach and abdominal distension due to indigestion, stomach pain, and gastric acidity. Very useful as an acid agent.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 高見 潔 富山県中新川郡上市町横法音寺55番地 富 士化学工業株式会社内 (72)発明者 稲垣 満二 富山県中新川郡上市町横法音寺55番地 富 士化学工業株式会社内 (72)発明者 村上 達夫 富山県中新川郡上市町横法音寺55番地 富 士化学工業株式会社内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Kiyoshi Takami 55 Kamiichi-cho, Kamiichi-cho, Toyama Prefecture Inside Fuji Chemical Industry Co., Ltd. Address Fuji Chemical Co., Ltd. (72) Inventor Tatsuo Murakami 55 Yokohoonji Temple, Kamiichi-cho, Nakashinagawa-gun, Toyama Prefecture Fuji Chemical Co., Ltd.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】水媒質中で、無機制酸剤、糖アルコール及
び崩壊剤を均一に分散させ、噴霧乾燥させることにより
得られる無機制酸剤含有速分散性造粒物。
1. An inorganic antacid-containing rapidly dispersible granule obtained by uniformly dispersing an inorganic antacid, a sugar alcohol and a disintegrant in an aqueous medium and spray-drying.
【請求項2】無機制酸剤が、水酸化アルミニウムゲル、
水酸化マグネシウム、メタケイ酸アルミン酸マグネシウ
ム、ケイ酸アルミン酸マグネシウム、合成ヒドロタルサ
イト、乾燥水酸化アルミニウムゲル、炭酸マグネシウ
ム、沈降炭酸カルシウムの群から選ばれる1種以上から
なる請求項1記載の無機制酸剤含有速分散性造粒物。
2. The inorganic antacid is aluminum hydroxide gel,
The inorganic compound according to claim 1, comprising at least one selected from the group consisting of magnesium hydroxide, magnesium metasilicate aluminate, magnesium aluminate silicate, synthetic hydrotalcite, dried aluminum hydroxide gel, magnesium carbonate, and precipitated calcium carbonate. Acid agent-containing rapidly dispersible granules.
【請求項3】制酸剤の配合量が造粒物の全量中、50〜
95重量%である請求項1〜2記載の無機制酸剤含有速
分散性造粒物。
3. The amount of the antacid is 50 to 50% of the total amount of the granulated product.
The inorganic antacid-containing fast-dispersing granule according to claim 1, which is 95% by weight.
【請求項4】糖アルコールがソルビトール、マンニトー
ル、キシリトール、還元麦芽糖水飴、エリスリトールか
らなる群から選ばれる1種以上からなる請求項1〜3記
載の無機制酸剤含有速分散性造粒物。
4. The inorganic antacid-containing fast-dispersing granule according to claim 1, wherein the sugar alcohol is at least one selected from the group consisting of sorbitol, mannitol, xylitol, reduced maltose syrup, and erythritol.
【請求項5】崩壊剤が、トウモロコシデンプン、デキス
トリン、カルメロースカルシウム、部分アルファー化デ
ンプンからなる群から選ばれる1種以上である請求項1
〜4記載の無機制酸剤含有速分散性造粒物。
5. The disintegrant is at least one selected from the group consisting of corn starch, dextrin, carmellose calcium, and partially pregelatinized starch.
5. The rapidly dispersible granulated product containing an inorganic antacid according to any one of items 4 to 4.
【請求項6】水媒質中で、無機制酸剤、糖アルコール及
び崩壊剤を均一に分散させ、噴霧乾燥させることを特徴
とする請求項1〜5記載の無機制酸剤含有速分散性造粒
物の製造方法。
6. The inorganic antacid-containing fast-dispersing composition according to claim 1, wherein the inorganic antacid, sugar alcohol and disintegrant are uniformly dispersed in an aqueous medium and spray-dried. A method for producing granules.
【請求項7】請求項1〜5記載の無機制酸剤含有速分散
性造粒物を有効成分として含有することを特徴とする用
時懸濁内服制酸剤。
7. An antacid preparation for oral use in suspension containing the inorganic antacid-containing fast-dispersing granules according to claim 1 as an active ingredient.
JP29450396A 1996-10-15 1996-10-15 Inorganic antacid containing fast dispersible granule, method for producing the same, and suspended internal antacid Expired - Lifetime JP3961596B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29450396A JP3961596B2 (en) 1996-10-15 1996-10-15 Inorganic antacid containing fast dispersible granule, method for producing the same, and suspended internal antacid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29450396A JP3961596B2 (en) 1996-10-15 1996-10-15 Inorganic antacid containing fast dispersible granule, method for producing the same, and suspended internal antacid

Publications (2)

Publication Number Publication Date
JPH10120554A true JPH10120554A (en) 1998-05-12
JP3961596B2 JP3961596B2 (en) 2007-08-22

Family

ID=17808625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29450396A Expired - Lifetime JP3961596B2 (en) 1996-10-15 1996-10-15 Inorganic antacid containing fast dispersible granule, method for producing the same, and suspended internal antacid

Country Status (1)

Country Link
JP (1) JP3961596B2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086537A (en) * 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd Inorganic compound saccharide composition, vehicle, rapidly disintegrating compression molded product, and their production
JP2002154940A (en) * 2000-11-16 2002-05-28 Nonogawa Shoji Kk Hair decolorant
JP2004536855A (en) * 2001-07-16 2004-12-09 アストラゼネカ・アクチエボラーグ Pharmaceutical formulations containing proton pump inhibitors and acid neutralizers
JP2005538213A (en) * 2002-09-05 2005-12-15 キンバリー クラーク ワールドワイド インコーポレイテッド Extrusion cleaning products
JPWO2005037254A1 (en) * 2003-10-15 2007-11-22 富士化学工業株式会社 Tablet Quickly Disintegrating in Oral Cavity
WO2010098417A1 (en) 2009-02-25 2010-09-02 協和化学工業株式会社 Magnesium oxide fine granules
US7838033B2 (en) 2003-10-15 2010-11-23 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
WO2011019045A1 (en) 2009-08-11 2011-02-17 富士化学工業株式会社 Disintegrating particle composition and orally rapidly disintegrating tablet
WO2011019046A1 (en) * 2009-08-11 2011-02-17 富士化学工業株式会社 Disintegrating particle composition and orally rapidly disintegrating tablet
JPWO2010092828A1 (en) * 2009-02-12 2012-08-16 富士化学工業株式会社 Disintegrating particle composition and fast disintegrating compression molding using the same
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
GB2561723A (en) * 2017-04-18 2018-10-24 Nature Pops Ltd A composition for oral administration
WO2023007766A1 (en) * 2021-07-30 2023-02-02 セトラスホールディングス株式会社 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086537A (en) * 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd Inorganic compound saccharide composition, vehicle, rapidly disintegrating compression molded product, and their production
JP2002154940A (en) * 2000-11-16 2002-05-28 Nonogawa Shoji Kk Hair decolorant
JP2004536855A (en) * 2001-07-16 2004-12-09 アストラゼネカ・アクチエボラーグ Pharmaceutical formulations containing proton pump inhibitors and acid neutralizers
JP2005538213A (en) * 2002-09-05 2005-12-15 キンバリー クラーク ワールドワイド インコーポレイテッド Extrusion cleaning products
US7838033B2 (en) 2003-10-15 2010-11-23 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
US8647668B2 (en) 2003-10-15 2014-02-11 Fuji Chemical Industry Co., Ltd. Tablet quickly disintegrating in oral cavity
JPWO2005037254A1 (en) * 2003-10-15 2007-11-22 富士化学工業株式会社 Tablet Quickly Disintegrating in Oral Cavity
JP4726628B2 (en) * 2003-10-15 2011-07-20 富士化学工業株式会社 Orally rapidly disintegrating tablets
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
JPWO2010092828A1 (en) * 2009-02-12 2012-08-16 富士化学工業株式会社 Disintegrating particle composition and fast disintegrating compression molding using the same
WO2010098417A1 (en) 2009-02-25 2010-09-02 協和化学工業株式会社 Magnesium oxide fine granules
AU2010218737B2 (en) * 2009-02-25 2014-07-31 Kyowa Chemical Industry Co., Ltd. Magnesium oxide granules
CN102333535A (en) * 2009-02-25 2012-01-25 协和化学工业株式会社 Magnesium Oxide Microparticles
JPWO2010098417A1 (en) * 2009-02-25 2012-09-06 協和化学工業株式会社 Magnesium oxide fine granules
WO2011019045A1 (en) 2009-08-11 2011-02-17 富士化学工業株式会社 Disintegrating particle composition and orally rapidly disintegrating tablet
WO2011019046A1 (en) * 2009-08-11 2011-02-17 富士化学工業株式会社 Disintegrating particle composition and orally rapidly disintegrating tablet
US8900602B2 (en) 2009-08-11 2014-12-02 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
JP5674667B2 (en) * 2009-08-11 2015-02-25 富士化学工業株式会社 Disintegrating particle composition and intraoral quick disintegrating tablet
JP5674666B2 (en) * 2009-08-11 2015-02-25 富士化学工業株式会社 Disintegrating particle composition and intraoral quick disintegrating tablet
US9446055B2 (en) 2009-08-11 2016-09-20 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
GB2561723A (en) * 2017-04-18 2018-10-24 Nature Pops Ltd A composition for oral administration
GB2561723B (en) * 2017-04-18 2022-06-08 Nature Pops Ltd A composition for oral administration
WO2023007766A1 (en) * 2021-07-30 2023-02-02 セトラスホールディングス株式会社 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
JPWO2023007766A1 (en) * 2021-07-30 2023-02-02
JP2023020835A (en) * 2021-07-30 2023-02-09 セトラスホールディングス株式会社 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
AU2021457908B2 (en) * 2021-07-30 2025-09-04 Setolas Holdings, Inc. Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
AU2021457908B9 (en) * 2021-07-30 2026-02-05 Setolas Holdings, Inc. Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
AU2025275199B2 (en) * 2021-07-30 2026-05-14 Setolas Holdings, Inc. Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Also Published As

Publication number Publication date
JP3961596B2 (en) 2007-08-22

Similar Documents

Publication Publication Date Title
JP4213867B2 (en) Method for preparing oral calcium composition
JP4748627B2 (en) Excipient
KR101590115B1 (en) Pharmaceutical compositions
JP6196676B2 (en) Rapidly disintegrating solid dosage formulation containing functionalized calcium carbonate and method for producing the same
JPWO1997031639A1 (en) Tablets containing β-lactam antibiotics and method for producing the same
WO1997031639A1 (en) TABLETS CONTAINING β-LACTAM ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME
JPWO2000003735A1 (en) excipients
WO2010021300A1 (en) Novel excipient for mannitol tableting
JP3961596B2 (en) Inorganic antacid containing fast dispersible granule, method for producing the same, and suspended internal antacid
JP3900245B2 (en) Intraoral rapidly disintegrating tablet and method for producing the same
CN103284968B (en) Oral cavity disintegration tablet of a kind of aripiprazole composition microcrystalline and preparation method thereof
JPH08502073A (en) Calcium polycarbophil sprinkle
JP2001322927A (en) Low substituted hydroxypropylcellulose-containing solid preparation and production method thereof
CN101401796A (en) Pramipexole orally disintegrating tablets and preparation method thereof
JP5799061B2 (en) Granular solid formulation containing tosufloxacin and polyvinylpyrrolidone
JP4596586B2 (en) Trehalose particles
JP7745371B2 (en) Zonisamide drug substance particles and their uses
EP0599767A1 (en) Process to prepare water-dispersable tablets containing diclofenac
CN114767652B (en) Polycarbofil calcium dry suspension and preparation method and application thereof
JP7360460B2 (en) Orally disintegrating tablet and its manufacturing method
JP5132090B2 (en) Epinastine hydrochloride dry syrup
AU2019306315B2 (en) Pharmaceutical composition in the form of a chewable tablet of diosmin or of a flavonoid moiety
CN101237850A (en) Pharmaceutical composition containing indomethacin and/or acemetacin
HK40128954A (en) Cool-melting granular composition and preparation method therefor
WO2020032159A1 (en) Particulate composition and production method therefor

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070418

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070517

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130525

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160525

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term